vimarsana.com

Page 9 - ஹைடெல்பெர்க் பல்கலைக்கழகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IVF Services Market Size To Value USD 25 6 Billion, Globally, By 2026

Search jobs IVF Services Market Size To Value USD 25.6 Billion, Globally, By 2026 Pune, Maharashtra, India, February 12 2021 (Wiredrelease) Allied Analytics –:In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems and single mothers & the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, and upsurge in disposable income worldwide drive the growth of the IVF services market globally. However, the In vitro fertilization services market growth is restricted by higher cost, complications associated with IVF treatment, and low awareness level for IVF in some underdeveloped regions.

CoCID project aims to develop soft X-ray microscope for visualizing cellular origin of diseases

CoCID project aims to develop soft X-ray microscope for visualizing cellular origin of diseases CoCID (Compact Cell Imaging Device), a €5.7 million, four-year, pan-European research and innovation project, funded through Horizon 2020, has officially commenced. CoCID is focused on the development of a soft X-ray-based methodology that enables fast and inexpensive three-dimensional imaging of whole internal structure of intact biological cells. The objective of CoCID is to develop a lab-scale, soft X-ray microscope, which can be used as a research tool to help scientists to understand the cellular origin of diseases. The benefits of this compact imaging device will be demonstrated through a series of virology use cases that enable researchers to decipher critical changes in cell morphology induced by viruses, such as SARS-CoV-2, in their host cell with the aim to identify possible targets for therapy suppressing virus replication and/or cellular responses of relevance to the virus

European soft x-ray microscopy project begins at UCD

European soft x-ray microscopy project begins at UCD The project aims to develop a soft x-ray microscope that can help scientists to understand the cellular origin of diseases. A four-year research project focused on the development of a soft x-ray microscope has officially commenced today (2 February). Compact Cell Imaging Device (CoCID) is a €5.7m pan-European research and innovation project, which will use soft x-ray-based methodology to enable fast and inexpensive three-dimensional imaging of whole internal structures of intact biological cells. This could provide valuable information for researchers to understand the disease pathways of viruses and aid the development of novel therapeutics. The project team hopes to achieve this by developing a lab-scale, soft x-ray microscope.

Self-collected nasal swabs may provide a reliable alternative to nasopharyngeal swabs

Self-collected nasal swabs may provide a reliable alternative to nasopharyngeal swabs Under certain conditions, antigen testing using self-collected swabs from the anterior nose may constitute a reliable alternative to antigen testing using nasopharyngeal swabs collected by health professionals. This is the conclusion drawn by a team of researchers from Charité - Universitätsmedizin Berlin and Heidelberg University Hospital. Results from their study have been published in the European Respiratory Journal. Rapid antigen tests may be less reliable than PCR tests, but their speed and simplicity make them an important complementary tool that can assist efforts to curb the current pandemic and reduce risks in certain day-to-day situations.

Antigen tests -- are self-collected nasal swabs a reliable option?

 E-Mail Under certain conditions, antigen testing using self-collected swabs from the anterior nose may constitute a reliable alternative to antigen testing using nasopharyngeal swabs collected by health professionals. This is the conclusion drawn by a team of researchers from Charité - Universitätsmedizin Berlin and Heidelberg University Hospital. Results from their study have been published in the European Respiratory Journal . Rapid antigen tests may be less reliable than PCR tests, but their speed and simplicity make them an important complementary tool which can assist efforts to curb the current pandemic and reduce risks in certain day-to-day situations. Rapid antigen tests are intended for use at the point of care. Confirming whether or not a person is infected and contagious at the time of testing, they can provide results in less than 30 minutes. This type of test could therefore be used to make it safer for people to visit a loved one in a care home or hospital. Desp

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.